Guilin Sanjin Pharmaceutical Management
Management criteria checks 3/4
Guilin Sanjin Pharmaceutical's CEO is Xun Zou, appointed in Dec 2022, has a tenure of 2.92 years. directly owns 1.18% of the company’s shares, worth CN¥107.99M. The average tenure of the management team and the board of directors is 2.9 years and 6.6 years respectively.
Key information
Xun Zou
Chief executive officer
CN¥2.5m
Total compensation
| CEO salary percentage | n/a |
| CEO tenure | 2.9yrs |
| CEO ownership | 1.2% |
| Management average tenure | 2.9yrs |
| Board average tenure | 6.6yrs |
Recent management updates
Recent updates
Investors Don't See Light At End Of Guilin Sanjin Pharmaceutical Co., Ltd.'s (SZSE:002275) Tunnel
Oct 28
Guilin Sanjin Pharmaceutical's (SZSE:002275) Anemic Earnings Might Be Worse Than You Think
Sep 04Guilin Sanjin Pharmaceutical (SZSE:002275) Is Due To Pay A Dividend Of CN¥0.30
May 23Guilin Sanjin Pharmaceutical Co., Ltd.'s (SZSE:002275) Subdued P/E Might Signal An Opportunity
May 22Does Guilin Sanjin Pharmaceutical (SZSE:002275) Deserve A Spot On Your Watchlist?
Apr 17CEO
Xun Zou (49 yo)
Mr. Xun Zou is Chairman of Guilin Sanjin Pharmaceutical Co., Ltd. from January 14, 2022. He was Vice Chairman, Executive VP & Secretary of the Board of Directors of Guilin Sanjin Pharmaceutical Co., Ltd.f...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Chairman of the Board & President | 2.9yrs | CN¥2.54m | 1.18% CN¥ 108.0m | |
| VP, CFO & Director | 15.3yrs | CN¥1.09m | 1.3% CN¥ 118.8m | |
| Personnel Administration Director | no data | CN¥1.04m | no data | |
| VP & Non-Independent Director | no data | CN¥1.18m | 3.87% CN¥ 355.4m | |
| Director & VP | 2.9yrs | CN¥1.30m | 0.10% CN¥ 9.4m | |
| VP & Secretary of the Board | 2.9yrs | CN¥1.25m | no data | |
| Accounting Supervisor | no data | no data | no data |
Experienced Management: 002275's management team is considered experienced (2.9 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Chairman of the Board & President | 15.7yrs | CN¥2.54m | 1.18% CN¥ 108.0m | |
| VP, CFO & Director | 17.9yrs | CN¥1.09m | 1.3% CN¥ 118.8m | |
| Personnel Administration Director | 2.9yrs | CN¥1.04m | no data | |
| VP & Non-Independent Director | 11.9yrs | CN¥1.18m | 3.87% CN¥ 355.4m | |
| Director & VP | 3.5yrs | CN¥1.30m | 0.10% CN¥ 9.4m | |
| Chairman of the Supervisory Board | 11.9yrs | no data | 0.024% CN¥ 2.2m | |
| Independent Director | 10.8yrs | CN¥80.00k | no data | |
| Independent Director | 6.6yrs | CN¥80.00k | no data | |
| Independent Director | 6.6yrs | CN¥80.00k | no data | |
| Director | 2.9yrs | CN¥1.02m | no data | |
| Director of the Lean Management Office & Employee Supervisor | 5.9yrs | no data | no data | |
| Non-Employee Supervisor | 2.9yrs | no data | no data |
Experienced Board: 002275's board of directors are considered experienced (6.6 years average tenure).
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/11/15 21:49 |
| End of Day Share Price | 2025/11/14 00:00 |
| Earnings | 2025/09/30 |
| Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Guilin Sanjin Pharmaceutical Co., Ltd. is covered by 4 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| null null | Everbright Securities Co. Ltd. |
| Hai Zhu Peng | Huatai Research |
| Tianyi Yan | SWS Research Co., Ltd. |